Gyma is Your Partner in Building Global Pharmaceutical Connections

A Trusted US Pharmaceutical Supplier

We have the integrity, experience and global strength to meet your company’s pharmaceutical needs, from ingredients to final products. With offices now in India, China and Europe, we are extending our commitment to growing the U.S. pharmaceutical industry and our role in it. Our long-time customers have trusted our knowledgeable and supportive team of experts for their delivery, development, research and manufacturing needs for decades.

A Wide Selection of APIs

Gyma is one of the leading sources for API products and manufacturing. We currently have over 1300 APIs in production and 300 under development or evaluation, covering 205 therapeutic classes. Our APIs have passed rigorous inspections and meet global pharmaceutical guidelines. With our wide selection, we’ve got you covered from A-Z. Below are some of our featured APIs.

Featured APIs

  • Acalabrutinib

  • Angiotensin II

  • Bempedoic Acid

  • Betadex Sulfobutyl Ether Sodium (SBECD)

  • Brivaracetam

  • Brilliant Blue

  • Cannabidiol

  • Darolutamide

  • Dydrogesterone

  • Elagolix

  • Etelcalcetide

  • Ethiodized Oil

  • Eribulin

  • Filgotinib

  • Ibrutinib

  • Lenvatinib

  • Methylene Blue

  • Migalastat

  • Remdesivir

  • Relugolix

  • Rimegepant

  • Roxadustat

  • Sacubitril/Valsartan

  • Safinamide

  • Semaglutide

  • Spinosad

  • Tafamidis

  • Trabectedin

  • Trifarotene

  • Upadacitinib

  • Vadadustat

  • Valbeanzine

  • Venetoclax

  • Voxelotor

Our New Antibody-Drug Conjugates (ADCs)



New Products

  • Ansamitocin P-3

    66584-72-3

  • Maytansinol

    57103-68-1

  • Mertansine (DM1)

    139504-50-0

  • SMCC-DM1

    1228105-51-8

  • MCC-DM1

    1228105-53-0

  • Lys-MCC-DM1

    1281816-04-3

  • DM4

    796073-69-3

  • SPDB-DM4

    1626359-62-3

  • Exatecan

    171335-80-1

  • Dxd

    1599440-33-1

  • Deruxtecan

    1599440-13-7

  • MMAE

    474645-27-7

  • MMAF

    745017-94-1

  • Vc-MMAE

    646502-53-6

  • Vc-MMAF

    863971-17-9

  • MC-MMAF

    863971-19-1

Our Services

Our Business Development team is committed to building new partnerships and nourishing existing relationships with leading companies around the world. As we grow our global network of pharmaceutical professionals, we are continuously expanding our product and service catalogues. Together we are revolutionizing the development, shipment, manufacturing, research and partnership opportunities available to clients.

Services include:

  • Gyma CDMO

  • Gyma API

  • Gyma Business Development

  • Scientific Affairs

  • Import and Shipping

Meet Our International Team of Partners

API

CDMO

CRO

CMO

Work With Us

Gyma is one of the leading sources for API products and manufacturing. Reach out to learn more about how we can work together.

Gyma Monthly News

Check out our monthly newsletter to stay on top of our latest partnerships, upcoming events and more.

January 2019
We look forward to seeing you at DCAT Week 2019, NYC, at the Omni Berkshire Hotel
February 2018
We look forward to seeing you at DCAT Week 2018, NYC, at the Omni Berkshire Hotel.
February 2017
We look forward to seeing you at DCAT Week 2017, NYC, at the Omni Berkshire.
August 2016
We look forward to seeing you at CPhI 2016 in Barcelona, Spain October 4th – 6th.
January 2015
Gyma looks forward to seeing you at DCAT 2015, March 17th-19th in NYC. Please visit our Hospitality Suite, 15R, at the Waldorf Astoria Hotel on the evening of March 19th. Gyma is proud to announce our newest CRO partner, Dorizoe, an India based world class Injectable products development company.